News
Search EMA's news announcements
25 new medicines recommended for approval; two with a new active substance
These vaccines will protect sheep and cattle from disease outbreaks of newly emerged serotype-3
Outcomes of the Committee for Veterinary Medicinal Products (CVMP) meeting
Investigation of risk of rare eye condition with semaglutide medicines
114 new medicines recommended for approval; 46 had a new active substance
Updated policies for committee members, experts and Management Board members effective from May 2025
Enhanced EU collaboration to allow faster and wider access to innovative health technologies
EMA and HMA update principles for identification and disclosure of commercially confidential information and personal data
EMA's Executive Director shares her end-of-year message and takes stock of EMA's work in 2024
The European Medicines Agency's (EMA) office is closed from 18:00 on 19 December 2024 to 08:30 on 6 January 2025